Announces AXS-05 Achieves Primary Endpoint in the ADVANCE-1 Pivotal Phase 2/3 Trial in Alzheimer’s Disease Agitation

$Axsome Therapeutics(AXSM)$
iPhone转发:0回复:1喜欢:0

全部评论

葫芦娃101504-27 18:26

老哥买了吗,这收益啧啧